Germany Delays List Of Patented Drugs Targeted For Price Controls

Law360, New York (April 22, 2004, 12:00 AM EDT) -- A German parliamentary group has postponed the completion of a list of patent-protected drugs for which public health insurers will pay fixed prices.

Nonetheless, fixed prices on patented drugs will be introduced as planned on January 1, 2005, the group said.

GBA, the parliamentary group representing doctors and health insurance funds in the German parliament, had to postpone its decision due to unsettled legislative issues, GBA head Rainer Hess told the Handelsblatt newspaper.

Germany’s public health insurance system is seeking to save 2.5 billion euro in...
To view the full article, register now.